StonvexLoading…
StonvexStonvexStonvexCore line items from INSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $166.19M | $191.24M | $167.29M | $245.32M |
Operating Income | $4.32M | $1.72M | $-35.96M | $-57.92M |
Net Income | $838.00K | $4.57M | $-46.19M | $-67.97M |
EPS (Diluted) | $-0.18 | $0.10 | $-4.32 | $-6.59 |
Total Assets | $93.81M | $100.00M | $121.80M | $159.95M |
Total Liabilities | $97.85M | $112.86M | $223.90M | $230.07M |
Cash & Equivalents | $24.89M | $39.60M | $2.41M | $7.14M |
Free Cash Flow OCF − CapEx | $6.53M | $33.42M | $5.73M | $-34.77M |
Shares Outstanding | 15.39M | 14.99M | 11.88M | 10.85M |